BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30582912)

  • 1. Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals.
    An P; Li J; Lu L; Wu Y; Ling Y; Du J; Chen Z; Wang H
    Eur J Pharmacol; 2019 Feb; 845():16-23. PubMed ID: 30582912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
    Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS
    Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
    Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
    Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells.
    Deng Q; Jiang G; Wu Y; Li J; Liang W; Chen L; Su Q; Li W; Du J; Wong CKC; Chen Z; Wang H
    J Hazard Mater; 2018 Aug; 355():1-9. PubMed ID: 29758456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene.
    Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yeganeh S; Elyasi A; Darvishi N; Hosseini V; Abdi M
    J Cell Physiol; 2020 Mar; 235(3):2631-2642. PubMed ID: 31508813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suberoylanilide hydroxamic acid (SAHA) promotes the epithelial mesenchymal transition of triple negative breast cancer cells via HDAC8/FOXA1 signals.
    Wu S; Luo Z; Yu PJ; Xie H; He YW
    Biol Chem; 2016 Jan; 397(1):75-83. PubMed ID: 26431101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
    Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
    Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer.
    Hsieh CL; Ma HP; Su CM; Chang YJ; Hung WY; Ho YS; Huang WJ; Lin RK
    Life Sci; 2016 Apr; 151():7-14. PubMed ID: 26926079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast cancer cells by inhibiting YAP/TAZ activity.
    Cao D; Zhu GY; Lu Y; Yang A; Chen D; Huang HJ; Peng SX; Chen LW; Li YW
    Biomed Pharmacother; 2020 Sep; 129():110462. PubMed ID: 32768952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells.
    Dasgupta T; Antony J; Braithwaite AW; Horsfield JA
    J Biol Chem; 2016 Jun; 291(24):12761-12770. PubMed ID: 27072133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aurora A kinase activates YAP signaling in triple-negative breast cancer.
    Chang SS; Yamaguchi H; Xia W; Lim SO; Khotskaya Y; Wu Y; Chang WC; Liu Q; Hung MC
    Oncogene; 2017 Mar; 36(9):1265-1275. PubMed ID: 27593935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis.
    Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yegane S; Elyasi A; Darvishi N; Hosseini V; Abdi M
    Iran Biomed J; 2020 Sep; 24(5):288-94. PubMed ID: 32429642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of histone deacetylase 8 gene deletion on breast cancer cellular mechanism in vitro and in vivo study.
    Rahmani G; Moloudi MR; Amini R; Rahimi K; Fathi F; Abdi M; Najafi R
    Life Sci; 2022 Dec; 311(Pt A):121156. PubMed ID: 36356894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
    Liu J; Ye L; Li Q; Wu X; Wang B; Ouyang Y; Yuan Z; Li J; Lin C
    J Pathol; 2018 Jan; 244(1):71-83. PubMed ID: 28991374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
    Vanaja GR; Ramulu HG; Kalle AM
    Cell Commun Signal; 2018 May; 16(1):20. PubMed ID: 29716651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.
    Kim YJ; Sung M; Oh E; Vrancken MV; Song JY; Jung K; Choi YL
    Cancer Biol Ther; 2018 Apr; 19(4):335-345. PubMed ID: 29333926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization.
    Chen W; Bai Y; Patel C; Geng F
    Biochem Biophys Res Commun; 2019 Dec; 520(2):263-268. PubMed ID: 31590917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 Triggers the Migration and Invasion of Oestrogen Receptor-Negative Breast Cancer Cells via Regulation of Hippo Pathways.
    Hou L; Xie S; Li G; Xiong B; Gao Y; Zhao X; Hu J; Deng S; Jiang J
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):549-557. PubMed ID: 29781562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.
    Zhang Y; Zou J; Tolbert E; Zhao TC; Bayliss G; Zhuang S
    FASEB J; 2020 Jun; 34(6):7295-7310. PubMed ID: 32281211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.